Cargando…
Increased RHAMM expression relates to ovarian cancer progression
BACKGROUND: Elevated hyaluronan-mediated motility receptor (RHAMM) has been reported to contribute to disease progression, aggressive phenotype and poor prognosis in multiple cancer types, however, RHAMM’s role in ovarian cancer (OC) has not been elucidated. Therefore, we sought to evaluate the role...
Autores principales: | Buttermore, Stephanie T., Hoffman, Mitchel S., Kumar, Ambuj, Champeaux, Anne, Nicosia, Santo V., Kruk, Patricia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618727/ https://www.ncbi.nlm.nih.gov/pubmed/28954627 http://dx.doi.org/10.1186/s13048-017-0360-1 |
Ejemplares similares
-
Urinary interleukin-1β levels among gynecological patients
por: Woolery, Kamisha T, et al.
Publicado: (2014) -
Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation
por: Anderson, Nicole S, et al.
Publicado: (2009) -
“RHAMM knockout” mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53
por: Chen, Xiang, et al.
Publicado: (2022) -
RHAMM Is a Multifunctional Protein That Regulates Cancer Progression
por: Messam, Britney J., et al.
Publicado: (2021) -
Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
por: Veiseh, Mandana, et al.
Publicado: (2015)